← Evidence map

ReviewPharmaceuticals (Basel, Switzerland)2020

CDK4/6 and MAPK-Crosstalk as Opportunity for Cancer Treatment.

Lisa Scheiblecker et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

30 papers cite it

2020
2021
2022
2023
2024
2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 33255177